Repurposing ribosome-targeting antibiotics to overcome resistance to venetoclax in acute myeloid leukemia

被引：1
|
作者：
Sharon, David [1 ]
Chan, Steven M. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Hematol & Med Oncol, Toronto, ON, Canada
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 02期
基金：
加拿大健康研究院;
关键词：
Acute myeloid leukemia; BCL-2; inhibitor; drug resistance; integrated stress response; antibiotics; mitochondrial translation; ABT-199;
D O I：
10.1080/23723556.2020.1712182
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Venetoclax, a selective B-cell lymphoma 2 inhibitor, has shown promise in the treatment of acute myeloid leukemia. However, the development of drug resistance limits its clinical efficacy. In our study, we discovered that ribosome-targeting antibiotics can be repurposed to overcome venetoclax resistance in AML cells through activation of the integrated stress response.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ribosome-targeting antibiotics and mechanisms of bacterial resistance
    Daniel N. Wilson
    Nature Reviews Microbiology, 2014, 12 : 35 - 48
  • [2] Ribosome-targeting antibiotics and mechanisms of bacterial resistance
    Wilson, Daniel N.
    NATURE REVIEWS MICROBIOLOGY, 2014, 12 (01) : 35 - 48
  • [3] Resistance-guided identification of ribosome-targeting antibiotics
    Wright, Gerard
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S203 - S203
  • [4] Ribosome-targeting antibiotics and resistance via ribosomal RNA methylation
    Jeremia, Learnmore
    Deprez, Benjamin E.
    Dey, Debayan
    Conn, Graeme L.
    Wuest, William M.
    RSC MEDICINAL CHEMISTRY, 2023, 14 (04): : 624 - 643
  • [5] Mutational Evolution of Pseudomonas aeruginosa Resistance to Ribosome-Targeting Antibiotics
    Sanz-Garcia, Fernando
    Hernando-Amado, Sara
    Martinez, Jose L.
    FRONTIERS IN GENETICS, 2018, 9
  • [6] An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia
    Przedborski, Michelle
    Sharon, David
    Cathelin, Severine
    Chan, Steven
    Kohandel, Mohammad
    PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (09)
  • [7] Venetoclax Resistance in Acute Myeloid Leukemia
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Collette, Yves
    Vey, Norbert
    CANCERS, 2024, 16 (06)
  • [8] The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics
    Polikanov, Yury S.
    Aleksashin, Nikolay A.
    Beckert, Bertrand
    Wilson, Daniel N.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2018, 5
  • [9] Synthesis of novel chloramphenicol derivatives as ribosome-targeting antibiotics
    Fernando, Payagala Udawattage Ashvin
    Gregory, Steven
    Donhue, Samantha
    DeBoef, Brenton
    Cesana, Paul
    Gerwald, Jogl
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [10] Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design
    Lin, Jinzhong
    Zhou, Dejian
    Steitz, Thomas A.
    Polikanov, Yury S.
    Gagnon, Matthieu G.
    ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87, 2018, 87 : 451 - 478
12345